documents: FDA-2010-P-0275-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-P-0275-0003 FDA FDA-2010-P-0275 Determinations that Product Withdrawal From Sale Was Not for Reasons of Safety or Effectiveness: GLEEVEC (Imatinib Mesylate) Capsules, 50 Milligrams and 100 Milligrams Notice N-Notice 2010-12-07T05:00:00Z 2010 12 2010-12-07T05:00:00Z   2010-12-07T15:24:43Z 2010-30570 0 0 0900006480bb0be6

Links from other tables